{"id":1014265,"date":"2026-10-27T17:43:43","date_gmt":"2026-10-27T21:43:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/"},"modified":"2026-10-27T17:43:43","modified_gmt":"2026-10-27T21:43:43","slug":"revolution-medicines-to-participate-in-november-2026-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/","title":{"rendered":"Revolution Medicines to Participate in November 2026 Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">REDWOOD CITY, Calif., Oct.  27, 2026  (GLOBE NEWSWIRE) &#8212; Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company\u2019s chief executive officer and chairman, will participate in two upcoming investor conferences.<\/p>\n<p align=\"left\">Details of the company\u2019s participation are as follows:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>3rd Annual Guggenheim Healthcare Innovation Conference 2026<\/strong><\/p>\n<ul type=\"circle\">\n<li style=\"text-align:justify\">Fireside Chat Date\/Time: Tuesday, November 10 at 8:30 a.m. ET<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Jefferies Global Healthcare Conference in London<\/strong><\/p>\n<ul type=\"circle\">\n<li style=\"text-align:justify\">Fireside Chat Date\/Time: Monday, November 16 at 5:30 a.m. ET<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p align=\"left\">To listen to a live webcast of any of these events, or access archived webcasts, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O6Pp59O8gorTkfCf2LEx489y4CluBiXUEHQvKa_zSbEQnFOtfQqc3Elar78rqqFkQTlV6JRhPLXwL6UW0um5b0j-G8gi438c_61GaCqvSNTrtA-QlQD0kSnoZQ83vphYY1TGb5WC6UPOSGLGzHVBHkh3a8YqqdlzMKxayxGCoKkjQw2Ou10_AcGf6r1sKgjz7CCflbYnAk9Vx9uEsLJmkyq8VdukNFCrjlaY3aUnOJxD4RGo9hkj78gXF_0uc2By9fSRBf0hE80HaH3JYcmmiKLke18-OdsDq46V05wlvsqeEbw-rK_cwpWLTVhJB2hFIyOU4pG5bwiLBdUrapKMQRZXVvSDXX9s5QvIZZPWr9TzHTsjYueL1tuvTi7HdIlO\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.revmed.com\/events-and-presentations<\/a>. Following the live webcasts, replays will be available on the company\u2019s website for at least 14 days.<\/p>\n<p align=\"left\">\n        <strong>About Revolution Medicines, Inc.<\/strong><br \/>\n        <br \/>Revolution Medicines is a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0zwZqCu-2eDcdP4fofEFplOb_8hWQUdd5bfBAEDHDAfuwKowlBNv-FwW3ptcA7uDoRD-YsW_ehoU76lSKLqNxs7tZ7EqvDazlQWl9drR2c182o4xlSf5xuf_Ph8s0mc8tVJkcIiuVgAxMbUKRAwXBaynw27h-yKggix4aRdG1c0rbNniBLkAsAJMYsmRdcEAqZ4UakbRyvybKAgZWNiPItLtzhmMwbWbFZUsih9PQN-z6pNivfOGtkCv2nx5CCXdtlz-y4Gzpq-zTHoaMPmcCDVX3TFri55zH2K9kPi_Nr2BbO2U-a1ljGNBIIkTbFNAW0YPrUBvoyO3pNaPJgtneSwUAIs2n-edXv6IMGpp5GyzKcsEI_rbkLyq7Z-xa_BRIDVB0y5ra_yf0qA-51-U_FJ4zWBZ1bqy4SBxo7FUzuk=\" rel=\"nofollow\" target=\"_blank\">www.revmed.com<\/a> and follow Revolution Medicines on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aiWRL6omNn5MiBxIgHps5BqzX-rrw1PMd35JyWWrP8mKBDLx3mAfwfaKd6ANADMlQYbhxbF3HjE-K6v3ckW8nFcxvwTBGjh1a4AS1u4yEleKQWL5nvYMUbyYiyZIiBfOgvCvsnzRuRT3H71YSTEL-QxRKRzpGSetEVS7ht2W6qjOlIlSpHmG_FdX_sD1UnK4dSBL7YGbsUDM8TI2AXl4B3t3lBTrK3pePPL8oxufdX5FAGvNlCuX9IBXCzQc-i7rmQWX5jlJCP9_Fgy8foMOE9ZlCM7PauuKxzVuzi9eNN4VXRjR47_Qa2nV89QgjBz-Qc_1TUBRoZ-ex2v7XZJM1nWGEG6kev1CrtGle0KSUXxqX1q__kIi6g41CUA17leM7L8fCTDnYYLpD-AAcyf_jUYOPJg0AWTm3lYWGzRVr88RoKzSENv_No1Pj_osTKrihUwM9eOGy_Lz8avoIi_LJVBXOZP9nBQ1NlJcy3dPVlo=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-oRkFA8VAJf6g6bnlqEzAiWymrabusxoa3L_EU8n5fW2BpL7a4FIIDsORJLT0jGjerRLA6_ScGHYViJy7ggVUQRRbyz4xRCdrt_zZBaR9m5AmvTAvTF1K-jr_2VSzBwQSiOe5KCzDA78nb8rVPt7RS6zlnzXfoDbdtPFkI41HORuVb35qFCkyRlUMUCBNxSirFbg1phk5nRRcWEze9Nk8Ast3prBmlbMWPsj-sYmWqsbKYiDFe4Pmqg7qmSBiFdwX75ObzLfx4ImMycpG7qDoV67D8InPRK8DgGJ60bN6vjY0uLA8At02uZ4sTJO44jIcQFzyTg2jxv6l-6dC2WklsSKVKWzv8Y6nTE5zvsWjnNyqhSxjzTEW70vd3m_xWF7\" rel=\"nofollow\" target=\"_blank\">X<\/a> (Twitter) and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8xtigMxhWV0li-YIaHhSQOr30hLVOV3XDxLKQCnhs8PDbY-9Rs1Slf1bCtoZ_26RqCjnyWswFd_b5pCZXamJftjUosHuQ_lDhM-jlPPuucEoVSiz1k-v3zUJdHHMmjDnxVABYKuc8xhc6e6Izr70eyu2SdKP0BDcJf2sbzwEULhoa4wBg0XyxazFSzdGUrzN8xO7zGs7ZmJdA5sGpOQimUKHUTTHngCAQgvOEqA7jFa3Eho9E881eR1IhK2-72VAjWHtw85LC1p5T5_46pTxYIMUMPw27H7Jj4y6Mu1yUyshA-sgB36njh2rXvbd3T3dZ1rBfCCIG-bHw0GxfgM3Q7GJJPnhnQFHppYHyK2bDL2KW4mxs-V_n24VXbD7vxU_9w_mznwpnd3cAlqBo5s1vqOeBz-F8vIC1gf1jRoTaEyX4aMgUs4mlp6X7Oqpja6S_eElEB0nw70QeZPHxIOIUUBND108IX0uhyVaABmvI28=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Revolution Medicines Media &amp; Investor Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yNEIvzby3zSDMIR3nxKvKM7UtAHFxsdxsk7I5ZgIvaZajiJzgRrARKQGWzTYbf2iaG4yIPRJNr0wXUc28LWeDfOWDNB4wHd_8rBdZ4K1Uzs=\" rel=\"nofollow\" target=\"_blank\">media@revmed.com<\/a><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Logt7gJxM2l3oCMEDmmDWZpH_0gjcglra5loKZxk_EQKl_FnTtBSyoE88qHD-yXO6rUOVj_DPVfnbn5CsSF4gTjfQVVyr7af528XLs4t2TM=\" rel=\"nofollow\" target=\"_blank\">investors@revmed.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTE1OGJkNDUtZDQ1Mi00ZTEwLTk1ZmQtNzM2NmIzYTA5Mzk0LTEyMDU1ODctMjAyNi0xMC0yNy1lbg==\/tiny\/Revolution-Medicines-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company\u2019s chief executive officer and chairman, will participate in two upcoming investor conferences. Details of the company\u2019s participation are as follows: 3rd Annual Guggenheim Healthcare Innovation Conference 2026 Fireside Chat Date\/Time: Tuesday, November 10 at 8:30 a.m. ET Jefferies Global Healthcare Conference in London Fireside Chat Date\/Time: Monday, November 16 at 5:30 a.m. ET To listen to a live webcast of any of these events, or access archived webcasts, please visit: https:\/\/ir.revmed.com\/events-and-presentations. Following the live webcasts, replays will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Revolution Medicines to Participate in November 2026 Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1014265","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company\u2019s chief executive officer and chairman, will participate in two upcoming investor conferences. Details of the company\u2019s participation are as follows: 3rd Annual Guggenheim Healthcare Innovation Conference 2026 Fireside Chat Date\/Time: Tuesday, November 10 at 8:30 a.m. ET Jefferies Global Healthcare Conference in London Fireside Chat Date\/Time: Monday, November 16 at 5:30 a.m. ET To listen to a live webcast of any of these events, or access archived webcasts, please visit: https:\/\/ir.revmed.com\/events-and-presentations. Following the live webcasts, replays will be &hellip; Continue reading &quot;Revolution Medicines to Participate in November 2026 Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T21:43:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Revolution Medicines to Participate in November 2026 Investor Conferences\",\"datePublished\":\"2026-10-27T21:43:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/\",\"name\":\"Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\",\"datePublished\":\"2026-10-27T21:43:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revolution-medicines-to-participate-in-november-2026-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolution Medicines to Participate in November 2026 Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk","og_description":"REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) &#8212; Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company\u2019s chief executive officer and chairman, will participate in two upcoming investor conferences. Details of the company\u2019s participation are as follows: 3rd Annual Guggenheim Healthcare Innovation Conference 2026 Fireside Chat Date\/Time: Tuesday, November 10 at 8:30 a.m. ET Jefferies Global Healthcare Conference in London Fireside Chat Date\/Time: Monday, November 16 at 5:30 a.m. ET To listen to a live webcast of any of these events, or access archived webcasts, please visit: https:\/\/ir.revmed.com\/events-and-presentations. Following the live webcasts, replays will be &hellip; Continue reading \"Revolution Medicines to Participate in November 2026 Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-27T21:43:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Revolution Medicines to Participate in November 2026 Investor Conferences","datePublished":"2026-10-27T21:43:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/","name":"Revolution Medicines to Participate in November 2026 Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=","datePublished":"2026-10-27T21:43:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NDEwNyM3OTA2NTU0IzIxOTQwMzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revolution-medicines-to-participate-in-november-2026-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Revolution Medicines to Participate in November 2026 Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1014265"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014265\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1014265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1014265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1014265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}